Synapse

← JHEP Reports

Papers in JHEP Reports

Page 8 · newest first

  1. Landscape of T-cell exhaustion heterogeneity and HBV integration in virus-related HCC revealed by whole-exome, transcriptome, and single-cell sequencingJHEP Reports · 2025
  2. Guideline-enhanced large language models outperform physician-test takers on EASL Campus quizzes multiple choice questionsJHEP Reports · 2025
  3. Tumor necrosis facilitates perihilar cholangiocarcinoma metastasis by ANGPTL6-augmented vessel permeability and tumor disseminationJHEP Reports · 2025
  4. Elevated FBXO45 promotes TFG ubiquitination and drives lung metastasis of hepatocellular carcinomaJHEP Reports · 2025
  5. Cystic fibrosis liver disease progression in the era of elexacaftor–tezacaftor–ivacaftorJHEP Reports · 2025
  6. Impact of tenofovir vs. entecavir treatment on progression of chronic hepatitis B: A nationwide cohort studyJHEP Reports · 2025
  7. Improving risk stratification and detection of early HCC using ultrasound-based deep learning modelsJHEP Reports · 2025
  8. Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunityJHEP Reports · 2025
  9. Predicting the need for early TIPS in patients with cirrhosis and ascites: More art than scienceJHEP Reports · 2025
  10. Hepatitis D epidemiology and access to diagnostic testing among healthcare providers in Africa: A multi-country surveyJHEP Reports · 2025
  11. Effectiveness and active ingredients of digital behaviour change interventions for MASLD: A systematic review and meta-analysisJHEP Reports · 2025
  12. Genetic risk score correlates with immune profile and risk of HCC and cirrhosis development in Hispanics with MASLDJHEP Reports · 2025
  13. Sex-based differences in survival after liver transplantation for colorectal cancer liver metastases: A multivariable analysisJHEP Reports · 2025
  14. Serum fibrosis marker M2BPGi-based novel score predicts survival of unresectable HCC undergoing immunotherapyJHEP Reports · 2025
  15. Cholangiocarcinoma in Denmark: Time-trends in incidence and mortalityJHEP Reports · 2025
  16. “The alcohol-harm paradox”: Understanding socioeconomic inequalities in liver diseaseJHEP Reports · 2025
  17. Navigating liver toxicity in the age of novel oncological agentsJHEP Reports · 2025
  18. Comparative risk of osteoporosis and fractures in chronic hepatitis B patients: Tenofovir disoproxil fumarate vs. entecavir in a Korean nationwide cohortJHEP Reports · 2025
  19. Myeloid TGF-β signaling shapes liver macrophage heterogeneity and metabolic liver disease pathogenesisJHEP Reports · 2025
  20. Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trialJHEP Reports · 2025
  21. Stiffness-activated hepatic stellate cells boost HCC migration via TGM2/ITGB1-mediated matrix remodeling and mitochondrial transferJHEP Reports · 2025
  22. Profiles of HBV DNA integration in humans with hepatitis B virus infection: Insights for antiviral treatmentJHEP Reports · 2025
  23. Genome-wide meta-analysis identifies nine loci associated with higher risk of hepatocellular carcinoma developmentJHEP Reports · 2025
  24. LSECtin attenuates hepatic Th17 expansion in a murine model of cirrhosis and signals through the LAG-3 receptorJHEP Reports · 2025
  25. GDF15 is associated with hepatocellular senescence and correlates with mortality in patients with alcohol-associated hepatitisJHEP Reports · 2025
  26. Plasma proteomic signature for preoperative prediction of microvascular invasion in HCCJHEP Reports · 2025
  27. Odevixibat treatment reverses severe phenotype of PFIC in a young adult: A real-life experience beyond the genetic diagnosisJHEP Reports · 2025
  28. All-cause and disease-specific mortality in young adults with MASLD: A nationwide cohort studyJHEP Reports · 2025
  29. Attributable burden of steatotic liver disease on cardiovascular outcomes in AsiaJHEP Reports · 2025
  30. Missed opportunities in HCV care: Trends in late diagnosis and treatmentJHEP Reports · 2025
  31. Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatideJHEP Reports · 2025
  32. Impact of genetic variants linked to liver fat and liver volume on MRI-mapped body compositionJHEP Reports · 2025
  33. Clinical burden of HDV in Spain: Incidence, prevalence, and associated comorbiditiesJHEP Reports · 2025
  34. Autoantibodies are associated with worse outcomes in MASLDJHEP Reports · 2025
  35. Risk of portal hypertensive complications preventable by TIPS in patients with ascitesJHEP Reports · 2025
  36. Modelling the liver’s regenerative capacity across different clinical conditionsSHILAP Revista de lepidopterología · 2025
  37. Endoscopic ultrasound-guided portosystemic pressure gradient measurement vs. transjugular balloon occlusion measurement in patients with cirrhosis (ENCOUNTER): A bicentric EU studyJHEP Reports · 2025
  38. Blood and tissue dysregulated bile acids and short-chain fatty acids in cholangiocarcinomaJHEP Reports · 2025
  39. Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-worldJHEP Reports · 2025
  40. Type II fibre atrophy and nuclear disruption in decompensated cirrhosisJHEP Reports · 2025
  41. Resolvin D1-mediated cellular crosstalk protects against MASHJHEP Reports · 2025
  42. Genetic variants influencing liver fat in normal-weight individuals of European ancestryJHEP Reports · 2025
  43. PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feedingJHEP Reports · 2025
  44. Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imagingJHEP Reports · 2025
  45. SBRT for bridging and downstaging HCC before transplantJHEP Reports · 2025
  46. Effect of liver biopsy size on MASLD fibrosis assessment by second-harmonic generation/two-photon excitation fluorescence microscopyJHEP Reports · 2025
  47. The association between stage migration and overall survival after radiation-based therapies in patients with hepatocellular carcinomaJHEP Reports · 2025
  48. Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatologyJHEP Reports · 2025
  49. Transjugular diagnostic procedures in hepatology: Indications, techniques and interpretationJHEP Reports · 2025
  50. Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparisonJHEP Reports · 2025